Metraipolis › archive › dc_c070bdb39e5b

PSMA-Targeted Radioligand Therapy Beyond the Post-Taxane Setting: A Review of Evidence Across the Prostate Cancer Spectrum — Europe PMC PMID:42449702

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449702
DOI
10.3390/cancers18132161
License (as archived)
solo-consultazione
Archived
2026-10-18T11:18:34.754Z
SHA-256 of the archived text
28c6376fdd5fd1dcc9a2a81e4693537a62e9f379fa3c7a0a2314f835b6c16071
Stable URL of this page
https://metraipolis.com/documento/dc_c070bdb39e5b

How to cite

PSMA-Targeted Radioligand Therapy Beyond the Post-Taxane Setting: A Review of Evidence Across the Prostate Cancer Spectrum — Europe PMC PMID:42449702 — Europe PMC (en), https://europepmc.org/article/MED/42449702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c070bdb39e5b (Metraipolis archive dc_c070bdb39e5b, sha256 28c6376fdd5fd1dcc9a2a81e4693537a62e9f379fa3c7a0a2314f835b6c16071)
BibTeX
@misc{dcc070bdb39e5b,
  title = {PSMA-Targeted Radioligand Therapy Beyond the Post-Taxane Setting: A Review of Evidence Across the Prostate Cancer Spectrum — Europe PMC PMID:42449702},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449702},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c070bdb39e5b; sha256 28c6376fdd5fd1dcc9a2a81e4693537a62e9f379fa3c7a0a2314f835b6c16071},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449702. Agents can read the archived copy with the MCP tool read_document.